Older adults with moderate to severe IBD can achieve remission with JAK inhibitors, according to a study presented at Crohn’s & Colitis Congress.

Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.

Ten members of the House have introduced a bill that would put a stop to the 2.83% cut in Medicare physician reimbursement.

Among children with high blood pressure, there are racial and ethnic disparities in receipt of nutrition, lifestyle, and weight counseling.